Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain.
de la Rubia J, Alonso R, Clavero ME, Askari E, García A, Antón C, Fernández M, Escalante F, García A, Rios-Tamayo R, Conesa V, Bermúdez MA, Merchán B, Velasco AE, Blanchard MJ, Sampol A, Gainza E, Hernández PM, Alegre A.
de la Rubia J, et al. Among authors: fernandez m.
Cancers (Basel). 2023 May 29;15(11):2964. doi: 10.3390/cancers15112964.
Cancers (Basel). 2023.
PMID: 37296925
Free PMC article.